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The Malaria-Protective Human Glycophorin
Structural Variant DUP4 Shows Somatic Mosaicism
and Association with Hemoglobin Levels
Walid Algady,1,9 Sandra Louzada,2,9 Danielle Carpenter,1 Paulina Brajer,1 Anna Fa¨rnert,3,4
Ingegerd Rooth,5 Billy Ngasala,6,7 Fengtang Yang,2 Marie-Anne Shaw,8 and Edward J. Hollox1,*
Glycophorin A and glycophorin B are red blood cell surface proteins and are both receptors for the parasite Plasmodium falciparum, which
is the principal cause of malaria in sub-Saharan Africa. DUP4 is a complex structural genomic variant that carries extra copies of a gly-
cophorin A-glycophorin B fusion gene and has a dramatic effect on malaria risk by reducing the risk of severe malaria by up to 40%.
Using fiber-FISH and Illumina sequencing, we validate the structural arrangement of the glycophorin locus in the DUP4 variant and
reveal somatic variation in copy number of the glycophorin B-glycophorin A fusion gene. By developing a simple, specific, PCR-based
assay for DUP4, we show that the DUP4 variant reaches a frequency of 13% in the population of a malaria-endemic village in south-
eastern Tanzania. We genotype a substantial proportion of that village and demonstrate an association of DUP4 genotype with
hemoglobin levels, a phenotype related to malaria, using a family-based association test. Taken together, we show that DUP4 is a
complex structural variant that may be susceptible to somatic variation and show that DUP4 is associated with a malarial-related
phenotype in a longitudinally followed population.Introduction
Structural variation (SV) of genomes, including inversions,
deletions, duplications, and more complex rearrange-
ments is seen at polymorphic frequencies across all species.
Like single-nucleotide variation, much SV is likely to be
evolving neutrally but in some cases there is evidence for
balancing or adaptive evolution.1–5 SV has also been
shown to generate novel genes with functional conse-
quences, for example generation of human-specific
SRGAP2 genes that increase the density of dendritic spines
in the brain.6,7 Regions that show extensive SVare thought
to have a high mutation rate, due to recurrent non-allelic
homologous recombination.8–11 In addition to SV in the
germline, large somatic SVs have been observed in human
brain,12 in skin fibroblasts,13 and in blood of identical
twins.14
Although SV is a source of variation between individ-
uals15 and between cells within an individual,16 its contri-
bution to disease resistance remains unclear, and the
best-characterized examples of structural variants associ-
ated with a common disease involve identifying an
inherited germline structural variant in linkage disequilib-
rium with a sentinel single-nucleotide variant (SNV) that
has been previously highlighted in a large genome-wide
association study.17
The human genome assembly carries three glycophorin
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120 kb repeats sharing 97% identity. Glycophorin A
(encoded by GYPA) and glycophorin B (encoded by
GYPB) are readily detectable on the surface of erythrocytes
and carry the MNS blood group system.18 Mature glyco-
phorin E (encoded by GYPE) is predicted to be 59 amino
acids long but has not been unambiguously detected on
the erythrocyte surface. The genomic region carrying these
genes is known to undergo extensive copy number varia-
tion and gene conversion, and rearrangements that shuffle
the coding regions of the three genes can generate rare
blood group antigens in the Miltenberger series (MIM:
111300).19 This genomic region has also been highlighted
as a region of balancing selection20–23 and positive
selection,24 though the effect of extensive gene conversion
between the 120 kb repeats on statistical measures of
positive selection is not clear.
Recent work studying the host genetic contribution to
severe malaria identified a SNV allele at a nearby non-
repeated region in linkage disequilibrium with a complex
structural variant at the glycophorin locus protective
against severe malaria.5,20 This structural variant, called
DUP4, is restricted to East African populations and is
responsible for a glycophorin B-glycophorin A fusion
gene product that is detected using serology as the blood
group antigen Dantu NEþ. This DUP4 variant confers a
clinically important protective effect, with carriers 40%
less likely to develop cerebral malaria.5 Given thatr LE1 7RH, UK; 2Wellcome Sanger Institute, Hinxton, Cambridge CB10 1SA,
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glycophorin A and glycophorin B are erythrocyte receptors
for the Plasmodium falciparum cell surface receptors MSP-1,
EBA-175, and EBL-1, respectively, it is likely that this
protective effect is mediated by an altered ability of the
parasite to invade the host erythrocyte.25–28
A model for the DUP4 variant, based on analysis of
mis-mapping positions of short-read sequences, was put
forward that involved a duplication of the GYPE gene,
deletion of the GYPB gene, and generation of two copies
of a GYPB-A fusion gene.5 It is not clear exactly how the
GYPB-A fusion protein confers protection against malaria,
but it has been suggested that it could affect interactions
with Plasmodium falciparum receptors and host band 3
protein at the erythrocyte surface.5 A complete character-
ization of the DUP4 allele is therefore important to
understand the mechanistic basis for this protective effect
and to facilitate design of treatments mimicking the mech-
anism of protection.Subjects and Methods
Study Population, Samples, and Phenotypic Data
The study population is from the coastal village of Nyamisati in
the Rufiji delta in Tanzania.29 Human genomic DNAwas extracted
from whole peripheral blood, as previously described,30 with
informed consent from participants or their guardians and
approval of the local ethics committees of the Muhimbili Univer-
sity of Health and Allied Sciences andNational Institute ofMedical
Research in Tanzania and the Regional Ethical Committee of
Stockholm in Sweden.
Phenotypic data spanning 7 years, from 1993 to 1999, was
collected using annual total population surveys and annual re-
cords of malarial episodes, as previously described.30 The total
population survey provided information on asymptomatic
parasite load (parasites per mL) and hemoglobin levels. A single
hemoglobin value was generated for each individual from annual
total population surveys carried out over 7 years, corrected for age,
sex, and parasite load prior to genetic analysis. A single parasite
load value was generated for each individual from asymptomatic
parasitemia recorded during annual total population surveys car-
ried out over 7 years. This single value was corrected for age and
sex prior to genetic analysis.
All clinical malarial episodes were recorded and confirmed by
microscopy. Multiple clinical episodes were recorded if the recur-
rence was greater than 4 weeks apart. A small proportion (1%) of
individuals presented with a clinical episode at the time of the to-
tal population survey, and these samples were included in the
analysis. A single clinical episode value was generated for each
individual from records of all malarial episodes occurring in the
village during a period of 7 years. The phenotypic data derived
for clinical episodes, parasite load, and hemoglobin have previ-
ously been described in detail.30,31Fluorescence In SituHybridization using Single-Molecule
DNA Fibers (Fiber-FISH)
The probes used in this study included four fosmid clones selected
from the UCSC Genome Browser GRCh37/hg19 assembly and a
3,632-bp PCR product that is specific for the glycophorin E repeat
(see below). Probes were made by whole-genome amplification770 The American Journal of Human Genetics 103, 769–776, Novemwith GenomePlex Whole Genome Amplification Kits (Sigma-
Aldrich) as described previously.32 Briefly, the purified fosmid
DNA and the PCR product were amplified and then labeled as
follows: G248P86579F1 and glycophorin E repeat-specific PCR
product were labeled with digoxigenin-11-dUTP, G248P8211G10
was labeled with biotin-16-dUTP, G248P85804F12 was labeled
with DNP-11-dUTP, and G248P80757F7 was labeled with
Cy5-dUTP. All labeled dUTPs were purchased from Jena
Bioscience.
The preparation of single-molecule DNA fibers by molecular
combing and fiber-FISH was as previously published,3,33 with the
exception of post-hybridization washes, which consisted of three
5-min washes in 23 SSC at 42C, instead of two 20-min washes in
50% formamide/50% 23 SSC at room temperature.Interphase-, Metaphase-FISH, and Karyotyping by
Multiplex-FISH
Metaphase chromosomes were prepared from a human lympho-
blastoid cell line (HG02554) purchased from Coriell Cell Reposi-
tories. Briefly, colcemid (Thermo Fisher Scientific) was added to a
final concentration of 0.1 mg/mL for 1 hr, followed by treatment
with hypotonic buffer (0.4% KCl in 10 mM HEPES [pH 7.4]) for
10 min and then fixed using 3:1 (v/v) methanol:acetic acid.
For interphase- and metaphase-FISH, G248P8211G10 labeled
with Texas Red-dUTP, G248P85804F12 labeled with Atto488-XX-
dUTP (Jena Bioscience), and RP11-325A24 labeled with Atto425-
dUTP (Jena Bioscience) were used as probes. Slides pre-treatments
included a 10-min fixation in acetone (Sigma-Aldrich), followed
by baking at 65C for 1 hr. Metaphase spreads on slides were dena-
tured by immersion in an alkaline denaturation solution (0.5 M
NaOH, 1.0 M NaCl) for 10 min, followed by rinsing in 1 M
Tris-HCl (pH 7.4) solution for 3 min, 13 PBS for 3 min, and dehy-
dration through a 70%, 90%, and 100% ethanol series. The probe
mix was denatured at 65C for 10 min before being applied onto
the denatured slides. Hybridization was performed at 37C over-
night. The post-hybridization washes included a 5-min strin-
gent-wash in 13 SSC at 73C, followed by a 5-min rinse in
23 SSC containing 0.05% Tween20 (VWR) and a 2-min rinse in
13 PBS, both at room temperature. Finally, slides were mounted
with SlowFade Gold mounting solution containing 406-diami-
dino-2-phenylindole (Thermo Fisher Scientific). Multiplex-FISH
(M-FISH) with human 24-color painting probe, as previously
described.34
Slides were examined using AxioImager D1 microscope
equipped with appropriate narrow-band pass filters for DAPI,
Aqua, FITC, Cy3, and Cy5 fluorescence. Digital image capture
and processing was carried out using the SmartCapture software
(Digital Scientific UK). Ten randomly selected metaphase cells
were karyotyped based on the M-FISH and DAPI-banding patterns
using the SmartType Karyotyper software (Digital Scientific UK).PCR for Fiber-FISH Probe Generation
The 3,632 bp glycophorin E repeat-specific PCR product for use as
a fiber-FISH probe was generated by long PCR. Long PCRs were
performed in a total volume of 25 mL using a Taq/Pfu DNA poly-
merase blend (0.6U Taq DNA polymerase/0.08U Pfu DNA poly-
merase), a final concentration of 0.2 mM primers Specific_glyco-
phorinE_F and and Specific_glycophorinE_R (Table S2), in
45 mM Tris-HCl (pH8.8), 11 mM (NH4)2SO4, 4.5 mM MgCl2,
6.7 mM 2-mercaptoethanol, 4.4 mM EDTA, 1 mM of each dNTP
(sodium salt), 113 mg/mL bovine serum albumin. Cyclingber 1, 2018
conditions were an initial denaturation of 94C for 1 min, a first
stage consisting of 20 cycles each of 94C for 15 s and 65C for
10 min, and a second stage consisting of 12 cycles each of 94C
for 15 s and 65C for 10 min (plus 15 s/cycle); these were followed
by a single incubation phase of 72C for 10 min.Illumina Sequencing of DUP4 Samples
1 mg genomicDNAwas randomly fragmented to a size of 350 bp by
shearing, DNA fragments were end polished, A-tailed, and ligated
with the NEBNext adaptor for Illumina sequencing, and further
PCR enriched by P5 and indexed P7 oligos. The PCR products
were purified (AMPure XP system) and the resulting libraries
were analyzed for size distribution by an Agilent 2100 Bioanalyzer
and quantified using real-time PCR.
Following sequencing on an Illumina platform, the resulting
150 bp paired-end sequences were examined for sequencing qual-
ity, aligned using BWA to the human reference genome (hg19 plus
decoy sequences), sorted using samtools35 and duplicate reads
marked using Picard, generating the final bam file. Sequencing
and initial bioinformatics was done by Novogene Ltd.
Sequence read depth was calculated using samtools to count
mapped reads in non-overlapping 5 kb windows across the glyco-
phorin region. Read counts were normalized for coverage to a non-
CNV region (chr4:145516270–145842585), then to the first 50 kb
of the glycophorin region which has diploid copy number of 2.DUP4 Junction Fragment PCR Genotyping
Primer sequences are shown in Table S2. PCR was conducted in a
final volume of 10 mL in 13 Kapa A PCR buffer (a standard ammo-
nium sulfate PCR buffer) with a final concentration of 1.5 mM
MgCl2, 10 ng genomic DNA, 0.2 mM of each of dATP, dCTP,
dGTP, and dTTP, 1U Taq DNA Polymerase, 0.1 mM each of
rs186873296F and rs186873296R, and 0.5 mM each of DUP4F2
and DUP4R2. Thermal cycling used an ABI Veriti Thermal cycler
with an initial denaturation of 95C for 2 min, followed by 35 cy-
cles of 95C 30 s, 58C 30 s, 70C 30 s, then followed by a final
extension of 70C for 5 min. 5 mL of each the PCR products were
analyzed using standard horizontal electrophoresis on an
ethidium-bromide-stained 2% agarose gel.
Routine genotyping included a DUP4 positive control in every
experiment (sample HG02554). We distinguished homozygotes
by quantification of DUP4 and control band intensity on agarose
gels using ImageJ, and calculating the ratio of DUP4:control band
intensity for each individual. At low allele frequencies, homozy-
gotes are expected to be rare. After log2 transformation, a cluster
of four outliers of high ratio (>2 SD, log2ratio > 1.43) were clearly
separated from the 278 other DUP4-positive samples, and these
four were classified as homozygotes. The remaining 278 DUP4-
positive samples were classified as heterozygotes.Family-Based Association Analysis
Associations between the three clinical phenotypes and DUP4 ge-
notype were tested using QTDT v.2.6.136 on the full dataset of 167
pedigrees, using an orthogonal model. The heritability for all the
clinical phenotypes was initially estimated using a model for poly-
genic variance. A test for total evidence of association was per-
formed which included all individuals within the samples, retain-
ing as much information as possible. This total test of association
included environmental, polygenic heritability, and additive ma-
jor locus variance components within the model. To control for
population stratification within family, association was tested inThe Americanan orthogonal model including environmental, polygenic herita-
bility, and additive major locus variance components. Direction of
effect was estimated by comparing the hemoglobin level values,
expressed as residuals from the regression model used to correct
for age and sex, between the 262 unrelated individuals with hemo-
globin level values from the Nyamisati cohort carrying (n ¼ 70,
mean ¼ 1.67 g/L, standard deviation ¼ 16.0 g/L) and not carrying
(n ¼ 192, mean ¼ 0.12 g/L, standard deviation ¼ 14.1 g/L) the
DUP4 variant.Results
The Physical Structure of the DUP4 Structural Variant
We initially decided to confirm this structural model by
physical mapping of the DUP4 variant using fiber-FISH.
We grew lymphoblastoid cells from the known DUP4 het-
erozygote from the 1000 Genomes project sample collec-
tion, HG02554, derived from a man with African ancestry
from Barbados, and selected clones to act as fiber-FISH
probes from the WIBR-2 human fosmid library spanning
the region, based on fosmid end sequences previously
mapped to the GRChr37 reference genome.
Fiber-FISH showed that the reference haplotype gener-
ates signals consistent with the genome reference
sequence (Figure 1A). Because of the high sequence iden-
tity between the tandemly repeated glycophorin regions,
there is extensive cross-hybridization of probes that map
to the GYPB repeat with the GYPE and GYPA repeats. The
GYPE repeat can be distinguished by hybridization of a
small GYPE-repeat-specific PCR product, and the GYPA
repeat can be identified by a gap in the green fosmid probe
signal, caused by 16 kb of unique sequence in the GYPA
repeat. Also, the overlap of the distal end of the blue fos-
mid probe with the proximal end of the GYPE repeat
means that a small amount of blue signal at the distal
end of the GYPB and GYPE repeats is detected, confirming
repeat length and orientation. We identified DNA fibers
showing an arrangement completely consistent with the
DUP4 model proposed previously (Figure 1B).
Identification of a Somatic DUP4 Variant
However, we also visualized fibers with an extra partial
repeat unit, which we called DUP4b (Figure 1C). This novel
variant carries an extra copy of the partial A-B repeat,
which harbors the GYPB/GYPA fusion gene. We selected
a fosmid probe that spanned the 16 kb insertion specific
to the GYPA repeat and showed that the extra copy was
at least partly derived from the A repeat, consistent with
the extra copy being an extra copy of the partial A-B repeat
(Figure S1).
To rule out large-scale karyotype changes being respon-
sible for our observations of the additional novel variant
(DUP4b), we analyzed metaphase spreads of HG02554
lymphoblastoid cell line usingmetaphase-FISH, interphase
FISH, and multiplex-FISH karyotyping (Figure S2). DUP4
and reference chromosomes could be distinguished by
interphase-FISH on the basis of hybridization intensity ofJournal of Human Genetics 103, 769–776, November 1, 2018 771
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Figure 1. Fiber FISH Analysis of the DUP4 Heterozygote Sample HG02554
(A) An example DNA fiber from the reference haplotype. The position and label color of the fosmid probes is indicated above the fiber on
a representation of the human reference genome, and the interpretation of the FISH signals shown below the fiber.
(B) An example DNA fiber from the DUP4a haplotype. The Leffler model of the DUP4 haplotype is indicated above the fiber. The
interpretation of the FISH signals shown below the fiber.
(C) An example DNA fiber from the DUP4b haplotype. The interpretation of the FISH signals is shown below the fiber.a fosmid probemapping toGYPB (Figure S2B). No evidence
of large-scale inter- and intrachromosomal rearrangements
or aneuploidy was found in any of our experiments.
We hypothesized that DUP4b is a somatic variant that
occurred through rearrangement of the original DUP4
variant (which we call DUP4a), but not the reference
variant. If this is true, we would expect to observe an equal
number of reference and DUP4 fibers from each of the
parental chromosomes confirming the heterozygous
DUP4 genotype of the source cells, but for the DUP4 fibers
to be subdivided into DUP4a and DUP4b variants. Of 24
fibers examined from HG02554, 12 were reference and
12 were DUP4, and, of the 12 DUP4 variants, 7 were
DUP4a and 5 were DUP4b, strongly supporting the model
where DUP4b is a somatic rearrangement of DUP4a and
the presence of two sub-clones (populations) of cells, one
with reference and DUP4a haplotypes the other with
reference and DUP4b haplotypes. We also analyzed the
HG02554 cell line from the Oxford laboratory used in their
study5 and confirmed the existence of DUP4b by fiber-
FISH. The high frequency of DUP4b variant chromosomes
within the cell lines together with the observation of
DUP4b in two cell line cultures suggests that DUP4b is a
somatic variant of DUP4a that has arisen prior to the
passage received by the Oxford laboratory or theWellcome772 The American Journal of Human Genetics 103, 769–776, NovemSanger Institute, either in the donor individual or early in
the cell-culturing process, perhaps increasing in frequency
due to the associated transformation cell bottleneck.37
To further characterize the somatic variation observed in
HG02554, we Illumina sequenced at high depth (503)
HG02554 DNA purchased directly from Coriell Cell
Repositories andextracted fromtheirHG02554 lymphoblas-
toid cell line rather than extracted from our cell lines,
together with peripheral-blood derived genomic DNA from
two Tanzanian DUP4 homozygotes and two Tanzanian
DUP4heterozygotes. Analysis of sequence read depth across
the glycophorin repeat region showed the same pattern as
that observed previously,5 leading to a model that is
confirmedbyourfiber-FISHdata (Figure2A).DUP4homozy-
gotes show the expected increase to four copies and six
copies in duplicated and triplicated regions, respectively.
We then compared the sequence read depth of HG02554
to the other two DUP4 heterozygotes to search for evi-
dence of an increased copy number of the BAB partial
repeat carrying the GYPA/GYPB fusion gene (Figure 1) sug-
gested by our fiber-FISH data, which would reflect somatic
mosaicism. HG02554 indeed shows a significant increase
in DNA dosage in regions matching the BAB partial repeat,
of around about 0.5, reflecting an extra copy of the region
in 50% of cells (Figure 2B).ber 1, 2018
AB
Figure 2. Sequence Read Depth Analysis
of DUP4 Homozygotes and Heterozygotes
(A) Normalized sequence read depth of
5 kb windows spanning the reference
sequence glycophorin region for five sam-
ples. The lines show the Loess regression
line (f ¼ 0.1) for homozygotes (blue) and
heterozygotes (green). Gene positions
and repeats, with respect to the reference
sequence, are shown above the plot.
(B) The difference in HG02554 sequence
read depth compared to the average
sequence read depth of the two other
heterozygotes C05E and C05P is shown
in 5 kb windows across the glycophorin re-
gion. Points highlighted in red are signifi-
cantly different (p < 0.01).Development of a Simple Robust DUP4 Genotyping
Assay
Having characterized the structure of DUP4 variants, we
designed a simple robust junction fragment PCR assay
that would allow detection of the DUP4 variant (both
DUP4a and DUP4b) in nanograms of genomic DNA, at a
large scale. This involved designing allele-specific and pa-
ralog-specific PCR primers across a known breakpoint, a
process mademore challenging by the high sequence iden-
tity between paralogs. DUP4-specific primers had a modi-
fied locked nucleic acid base incorporated in the terminal
30 nucleotide to enhance specificity for the correct pa-
ralog.38 We initially targeted the GYPA-GYPB breakpoint
that created the fusion gene but found that a similar break-
point was present in a frequent gene conversion allele. We
therefore designed primers to target the breakpoint be-
tween the GYPE repeat and the GYPB repeat, which was
predicted to be unique to DUP4.
The DUP4 genotype was determined using a duplex PCR
approach, with one pair of primers specific for the DUP4
variant and a second pair amplifying across the SNP
rs186873296, outside the structurally variable region,
acting as a control for PCR amplification. The assay was
validated against control samples showing different struc-
tural variants,5 and samples showing no structural varia-
tion, to ensure DUP4 specificity (Table S1, Figure S3).
Association of DUP4 with Malaria-Related Phenotypes
The DUP4 genotyping assay allowed us to investigate the
association of DUP4 with three quantitative traits relatedThe American Journal of Human Genetto malaria: hemoglobin levels in pe-
ripheral blood, parasite load, and
mean number of clinical episodes of
malaria, with hemoglobin levels
showing the highest heritability of
the three phenotypes in this cohort
(Table 1). The DUP4 structural variant
has previously been associated with
both severe cerebral malaria and se-
vere malarial anemia,5,39 and bothare diagnoses related to our quantitative traits. For
example, although the causes of hemoglobin level varia-
tion between individuals from a malaria-endemic region
will be multifactorial, they will be strongly affected by
malaria infection status of the individual, with infected in-
dividuals showing lower levels of hemoglobin.40 At the
extreme low end of the distribution of hemoglobin levels
is anemia, a sign of malaria that is one important feature
in the pathology of the disease.41
We analyzed data from a longitudinal study of a popula-
tion from the village of Nyamisati, in the Rufiji river delta,
150 km south of Dar-es-Salaam, Tanzania, described previ-
ously.29–31 This region was holoendemic for malaria,
predominantly P. falciparum, which causes 99.5% of all re-
corded clinical episodes of malaria. Parasite prevalence was
recorded as 75% at the start of the study in 1993, falling to
48% in 1998, as measured by microscopy in the 2- to
9-year-old children. A total of 962 individuals with pedi-
gree information were genotyped; of these 278 were
DUP4 heterozygotes and 4were DUP4 homozygotes. Previ-
ous work has suggested that the DUP4 variant is at a fre-
quency of about 3% in the Wasambaa of north-eastern
Tanzania,5 and our analysis found an allele frequency of
13.4% (95% confidence intervals 11.0%–16.1%) in the
348 unrelated individuals fromNyamisati village. For these
unrelated individuals, 87 were DUP4 heterozygotes and
3 were DUP4 homozygotes, with genotype frequencies in
Hardy-Weinberg equilibrium. We used the pedigree and
genotype information from our full cohort to test for
association of three malaria-related phenotypes with theics 103, 769–776, November 1, 2018 773
Table 1. Association of DUP4 Allele with Malarial Phenotypes in the Nyamisiti Cohort
Phenotype Heritability of Phenotype (95% CI)a Individuals Association p Value
Hemoglobin 0.302 (0.136–0.469) 800 0.0054
Parasite load 0.104 (0.002–0.206) 864 0.39
Clinical episodes 0.221 (0.131–0.311) 939 0.72
aCalculated on this cohort using SOLAR30,31,46DUP4 variant. Using a family-based association method
modeled in QTDT,36 we found a statistically significant
association of the DUP4 variant with hemoglobin levels
(p ¼ 0.0054, Table 1). We estimated the direction of effect
by comparing the mean corrected hemoglobin levels of
unrelated individuals with and without the DUP4 variant.
Individuals with the DUP4 allele showed a higher hemo-
globin level compared to those without a DUP4 variant,
showing that DUP4 variant is associated with higher he-
moglobin levels.Discussion
In summary, we directly demonstrate that the DUP4
variant has a complex structure involving a duplication
of GYPE, deletion of GYPB, and generation of two GYPB/
GYPA fusion genes. The evolution of this particular rear-
rangement remains unclear. Amodel involving three inter-
mediates has been suggested but none of these putative in-
termediates have yet been found.5 Given the relatively
limited numbers of individuals analyzed for glycophorin
structural variation so far, it is possible that these interme-
diate variants are rare or have been lost from the popula-
tion. Indeed, given the extensive structural variation seen
already at this locus, it seems likely that a high rate of
genomic rearrangement generates complex variants that
are mostly lost by genetic drift, with a few, such as DUP4,
increasing in frequency due to positive selection. Further
studies on the extensive variation in Africa are needed to
fully characterize the variation at this locus.
We show that the DUP4 variant is associated with hemo-
globin levels in a community setting indicating protection
from malaria. Low levels of hemoglobin indicate anemia,
which can reflect sub-clinical levels of malaria infection,
and the village studied has a very high prevalence of
P. falciparum infection, so our study supports the impor-
tance of the DUP4 variant in malaria protection. However,
the absence of an association with either the number of
clinical episodes of malaria or the parasite load is perhaps
more puzzling. This may reflect the lower heritability of
these traits compared to hemoglobin levels, and therefore
the increased effect of non-genetic variation (Table 1). A
recent case-control study of severe malaria in Kenyan chil-
dren found an association of DUP4 with higher hemoglo-
bin levels but not with parasite load, repeating the results
we present here.39 How DUP4 protects against malaria is
unknown and alternatively these results may point to a774 The American Journal of Human Genetics 103, 769–776, Novemrole in directly affecting erythrocyte invasion by the para-
site, which is detectable in our cohort, rather than the
more general phenotypes such as number of clinical ma-
laria episodes or parasite load.
We also show that a novel somatic variant exists (DUP4b)
with an extra GYPB/GYPA fusion gene, suggesting that this
regionmay be prone to somatic rearrangements.We cannot
rule out a somatic rearrangement in the transformation and
culturing of the lymphoblastoid cell line, although it has
been shown previously that such genetic changes intro-
duced by EBV transformation are either rare15,42 or overlap
with regions known to undergo extensive programmed so-
matic rearrangement, such as the immunoglobulin loci.43 It
is possible, therefore, that the somatic variant originated in
the donor patient given that the HG02554 B-lymphoblas-
toid cells from Oxford and the Wellcome Sanger Institute
were both from the same batch of cells (passage #4, accord-
ing to Coriell Cell Repositories); recent evidence suggests
that such structural variant mosaics are likely to occur at a
significant frequency, at least at certain loci.44,45 We
demonstrate that this somatic variant is able to be detected
from high coverage short read sequence data, which will
allow further analysis of somatic variation at this locus
without cell material. Our data raise the intriguing
possibility of heightened somatic instability and somatic
mosaicism at this locus in DUP4 carriers, which might
confer added protection against malaria.Accession Numbers
Sequence data are available from the European Nucleotide Archive
for HG02554 (accession number ERP110671) and European
Genome-Phenome Archive for the four Tanzanian samples (study
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